[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368797-105":59,"doc-detail-368797-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","resveratrol-sensitising-cd44-cervical-cancer-cells-to-carboplatin-and-mitigating-metastasis","Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis","","Cervical cancer remains a leading cause of cancer-related mortality, with high-risk HPV driving carcinogenesis and outcomes often limited by metastasis and chemoresistance. CD44, a marker linked to cancer stem cells, is implicated in both metastatic progression and drug resistance. This review evaluates evidence for CD44’s role in cervical cancer and the potential of resveratrol to chemo-sensitise cervical cancer cells to carboplatin, while reducing metastatic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/resveratrol-sensitising-cd44-cervical-cancer-cells-to-carboplatin-and-mitigating-metastasis/368797/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/resveratrol-sensitising-cd44-cervical-cancer-cells-to-carboplatin-and-mitigating-metastasis/368797.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is CD44 considered important in cervical cancer progression?","Question",{"text":112,"@type":113},"CD44 is associated with cancer stem cell traits and has been repeatedly linked to processes involved in cervical cancer progression, including drug resistance, EMT, and stemness.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How might resveratrol improve carboplatin effectiveness?",{"text":117,"@type":113},"Resveratrol has shown chemo-sensitising and antimetastatic effects in multiple malignancies, often involving modulation of CD44 and related pathways, suggesting a potential benefit when combined with carboplatin.",{"name":119,"@type":110,"acceptedAnswer":120},"What limitations exist in the current evidence for cervical cancer?",{"text":121,"@type":113},"Direct evidence specifically in cervical cancer remains limited, so further cervical-specific studies are needed to validate combining resveratrol with carboplatin to overcome CD44-mediated resistance and metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368797,1790330436,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Medicine  \nREVIEW  OPEN ACCESS   \nResveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis  \nCayleigh de Sousa  | Carla Eksteen  | Anna-Mart Engelbrecht   \nDepartment of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa Correspondence: Anna-Mart Engelbrecht ([ame@sun.ac.za](ame@sun.ac.za))  \nReceived: 10 March 2025 | Revised: 7 May 2025 | Accepted: 21 August 2025  \nFunding: This work was supported by National Research Foundation of South Africa, 138118; South African Medical Research Council; Technology Innovation Agency; Cancer Association of South Africa.  \nKeywords: carboplatin | CD44 | cervical cancer | chemo-sensitivity | metastasis  \nABSTRACT  \nBackground: Cervical cancer remains a leading cause of cancer-related mortality among women globally. Persistent infection with high-risk human papillomavirus drives cervical carcinogenesis, and treatment outcomes are frequently challenged by metastasis and chemoresistance. The transmembrane glycoprotein cluster of differentiation 44 (CD44), a marker associated with cancer stem cells (CSCs), has emerged as a critical mediator of both processes in cervical cancer.  \nObjective: This review aims to critically evaluate current evidence on the role of CD44 in cervical cancer progression, metastasis, and treatment resistance. It also explores the potential of resveratrol, a naturally occurring polyphenol with known anticancer properties, as a chemo-sensitizing agent to carboplatin therapy.  \nMethods: A comprehensive review of the literature was conducted using databases such as PubMed, Google Scholar, and Scopus to identify studies that investigate CD44-mediated mechanisms in cervical cancer, as well as the modulatory and mechanistic effects of resveratrol on CD44 and chemoresistance across various cancer types.  \nResults: CD44 has been consistently implicated in promoting drug resistance, epithelial-to-mesenchymal transition (EMT), and stemness in cervical cancer. Resveratrol has demonstrated antimetastatic and chemo-sensitizing effects in several malignancies, such as colorectal and breast cancers, often through modulation of CD44 and associated pathways. However, direct evidence in cervical cancer remains limited.  \nConclusion: Current findings suggest a promising therapeutic avenue for combining resveratrol with carboplatin to overcome CD44-mediated treatment resistance and metastasis in cervical cancer. Nonetheless, further cervical-specific studies are needed to validate this approach. A clearer understanding of this relationship may facilitate lower chemotherapy dosing, reduced toxicity, and improved clinical outcomes.  \n1 | Introduction  \nCervical cancer continues to be a serious public health threat among women worldwide [1], with high-risk human papillomavirus (HPV) infections being central to cervical malignancy. Recurring high-risk HPV infections account for 90% of all diagnosed cases [2], and although persisting HPV infections are  \nnecessary for cervical tumourigenesis, they are insufficient when acting alone. It is the combination of recurring high-risk HPV subtype infections, particularly HPV-16 and HPV-18, alongside other established cancer-associated risk factors that prompt cervical malignant behaviour [3] . HPV's tumourigenesis potential is primarily attributed to its high-risk subtype oncogene production of E6 and E7, which promote dysregulated cell signalling  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2025 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine, 2025; 14:e71194 1 of 18  \n[https://doi.org/10.1002/cam4.71194](https://doi.org/10.1002/cam4.71194)  \npathway activities, immune evasion, and genetic instability [4] . Therefore, early detection and preventative strategies, such ","cbCaiacjGNaXD6xL","https://ap.wps.com/l/cbCaiacjGNaXD6xL","pdf",1035737,18,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"Why is CD44 considered important in cervical cancer progression?\",\"answer\":\"CD44 is associated with cancer stem cell traits and has been repeatedly linked to processes involved in cervical cancer progression, including drug resistance, EMT, and stemness.\"},{\"question\":\"How might resveratrol improve carboplatin effectiveness?\",\"answer\":\"Resveratrol has shown chemo-sensitising and antimetastatic effects in multiple malignancies, often involving modulation of CD44 and related pathways, suggesting a potential benefit when combined with carboplatin.\"},{\"question\":\"What limitations exist in the current evidence for cervical cancer?\",\"answer\":\"Direct evidence specifically in cervical cancer remains limited, so further cervical-specific studies are needed to validate combining resveratrol with carboplatin to overcome CD44-mediated resistance and metastasis.\"}]","Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis | PDF",1790178590,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/69afd39ccc2384f7c78c438012890074.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d849600470b256264d16f44881f799ac.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cefbd3ebd77cd0c0a123e36108e0b0be.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64adc52bda26cfb4a9c974178ce1096e.webp",980,1287]